| 1 | female gonad development (GO:0008585) | 8.44842988 |
| 2 | regulation of telomere maintenance via telomerase (GO:0032210) | 8.03060149 |
| 3 | stress granule assembly (GO:0034063) | 7.18110262 |
| 4 | inner mitochondrial membrane organization (GO:0007007) | 6.79231333 |
| 5 | central nervous system neuron axonogenesis (GO:0021955) | 6.75834005 |
| 6 | male meiosis (GO:0007140) | 6.56734852 |
| 7 | cranial suture morphogenesis (GO:0060363) | 6.49441857 |
| 8 | negative regulation of telomere maintenance (GO:0032205) | 6.44702629 |
| 9 | peptidyl-lysine dimethylation (GO:0018027) | 6.23996726 |
| 10 | regulation of G0 to G1 transition (GO:0070316) | 6.21701792 |
| 11 | thyroid hormone generation (GO:0006590) | 6.14071358 |
| 12 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 5.87816573 |
| 13 | response to hepatocyte growth factor (GO:0035728) | 5.87816573 |
| 14 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 5.80759150 |
| 15 | centrosome duplication (GO:0051298) | 5.80282281 |
| 16 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 5.69773613 |
| 17 | lipid translocation (GO:0034204) | 5.62629355 |
| 18 | phospholipid translocation (GO:0045332) | 5.62629355 |
| 19 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 5.49658732 |
| 20 | regulation of protein glycosylation (GO:0060049) | 5.42719066 |
| 21 | apoptotic DNA fragmentation (GO:0006309) | 5.31035124 |
| 22 | positive regulation of keratinocyte differentiation (GO:0045618) | 5.26290659 |
| 23 | viral protein processing (GO:0019082) | 5.09710791 |
| 24 | DNA strand renaturation (GO:0000733) | 5.02938568 |
| 25 | thyroid hormone metabolic process (GO:0042403) | 5.01360550 |
| 26 | intermediate filament cytoskeleton organization (GO:0045104) | 4.87999954 |
| 27 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.79319917 |
| 28 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.79319917 |
| 29 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.79319917 |
| 30 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 4.75355269 |
| 31 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 4.75355269 |
| 32 | intermediate filament-based process (GO:0045103) | 4.73916020 |
| 33 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.66108144 |
| 34 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.66108144 |
| 35 | heart trabecula morphogenesis (GO:0061384) | 4.42885479 |
| 36 | negative regulation of glycoprotein metabolic process (GO:1903019) | 4.41290852 |
| 37 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.34777790 |
| 38 | maintenance of protein location in nucleus (GO:0051457) | 4.17712843 |
| 39 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 4.13646131 |
| 40 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.12929847 |
| 41 | regulation of sister chromatid cohesion (GO:0007063) | 4.11200191 |
| 42 | craniofacial suture morphogenesis (GO:0097094) | 4.04222767 |
| 43 | mitotic G2 DNA damage checkpoint (GO:0007095) | 3.98390149 |
| 44 | trabecula morphogenesis (GO:0061383) | 3.87446366 |
| 45 | regulation of telomere maintenance (GO:0032204) | 3.85008471 |
| 46 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.81204564 |
| 47 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.79891023 |
| 48 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.79610722 |
| 49 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.77880588 |
| 50 | galactose metabolic process (GO:0006012) | 3.77151501 |
| 51 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.66401512 |
| 52 | intracellular protein transmembrane import (GO:0044743) | 3.60000861 |
| 53 | negative regulation of receptor activity (GO:2000272) | 3.57466372 |
| 54 | regulation of histone phosphorylation (GO:0033127) | 3.55461731 |
| 55 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.54044655 |
| 56 | embryonic heart tube development (GO:0035050) | 3.53115550 |
| 57 | vitamin transmembrane transport (GO:0035461) | 3.48375124 |
| 58 | middle ear morphogenesis (GO:0042474) | 3.46034417 |
| 59 | reactive oxygen species biosynthetic process (GO:1903409) | 3.43147377 |
| 60 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 3.42162986 |
| 61 | parturition (GO:0007567) | 3.39689398 |
| 62 | protein-cofactor linkage (GO:0018065) | 3.36697839 |
| 63 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.36164184 |
| 64 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) | 3.34977950 |
| 65 | mast cell activation (GO:0045576) | 3.29234813 |
| 66 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 3.28207148 |
| 67 | regulation of membrane lipid distribution (GO:0097035) | 3.27445859 |
| 68 | natural killer cell activation (GO:0030101) | 3.23555015 |
| 69 | head development (GO:0060322) | 3.21861584 |
| 70 | androgen biosynthetic process (GO:0006702) | 3.21577184 |
| 71 | cell migration involved in heart development (GO:0060973) | 3.21470871 |
| 72 | outer ear morphogenesis (GO:0042473) | 3.21138026 |
| 73 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.10927382 |
| 74 | mitotic G2/M transition checkpoint (GO:0044818) | 3.10891485 |
| 75 | ATP synthesis coupled proton transport (GO:0015986) | 3.07537997 |
| 76 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.07537997 |
| 77 | peptidyl-lysine methylation (GO:0018022) | 3.04753271 |
| 78 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.97175868 |
| 79 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.96694950 |
| 80 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.95136836 |
| 81 | ovulation cycle (GO:0042698) | 2.88030812 |
| 82 | RNA destabilization (GO:0050779) | 2.87391506 |
| 83 | regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516) | 2.85157531 |
| 84 | endocardial cushion morphogenesis (GO:0003203) | 2.83636444 |
| 85 | virion assembly (GO:0019068) | 2.79418600 |
| 86 | regulation of keratinocyte proliferation (GO:0010837) | 2.77602807 |
| 87 | superoxide anion generation (GO:0042554) | 2.76090707 |
| 88 | negative regulation of cation channel activity (GO:2001258) | 2.75588086 |
| 89 | histone H3-K4 trimethylation (GO:0080182) | 2.75386813 |
| 90 | negative regulation of catenin import into nucleus (GO:0035414) | 2.74961379 |
| 91 | intracellular protein transmembrane transport (GO:0065002) | 2.73061279 |
| 92 | embryonic hindlimb morphogenesis (GO:0035116) | 2.72024373 |
| 93 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.70006628 |
| 94 | vitamin transport (GO:0051180) | 2.67664174 |
| 95 | neurofilament cytoskeleton organization (GO:0060052) | 18.2071320 |
| 96 | regulation of DNA methylation (GO:0044030) | 14.0017510 |
| 97 | glyoxylate metabolic process (GO:0046487) | 11.1593810 |
| 98 | ectoderm development (GO:0007398) | 10.9664226 |
| 99 | chaperone-mediated protein transport (GO:0072321) | 10.9176387 |
| 100 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 10.5391544 |
COX17P1 
